Europe & Central Asia (IDA & IBRD countries) vs Monaco: Immunization, HepB3
Europe & Central Asia (IDA & IBRD countries)
92.7%
in 2024
Monaco
99.0%
in 2024
Europe & Central Asia (IDA & IBRD countries) rank
4th
Monaco rank
1st
Immunization, HepB3 over time
- Europe & Central Asia (IDA & IBRD countries)
- Monaco
How they compare
Monaco currently reports 99.0% against 92.7% in Europe & Central Asia (IDA & IBRD countries), a difference of 6.3%.
That makes Monaco's figure about 1.1 times Europe & Central Asia (IDA & IBRD countries)'s.
Across all 26 years both countries report, Monaco has been ahead every year.
Europe & Central Asia (IDA & IBRD countries) ranks 4th and Monaco ranks 1st of 47 groups.
Monaco has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Europe & Central Asia (IDA & IBRD countries) | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 18.2% | 99.0% | 80.8% | Monaco |
| 2000s | 79.9% | 99.0% | 19.1% | Monaco |
| 2010s | 92.0% | 99.0% | 7.0% | Monaco |
| 2020s | 93.3% | 99.0% | 5.7% | Monaco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Europe & Central Asia (IDA & IBRD countries) or Monaco?
- Monaco, at 99.0% against 92.7% in Europe & Central Asia (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hepb3 between Europe & Central Asia (IDA & IBRD countries) and Monaco?
- 6.3%, with Monaco ahead.
- How many years of comparable data are there for Europe & Central Asia (IDA & IBRD countries) and Monaco?
- 26 years are reported by both, from 1999 to 2024.
- How do Europe & Central Asia (IDA & IBRD countries) and Monaco rank globally for immunization, hepb3?
- Europe & Central Asia (IDA & IBRD countries) ranks 4th and Monaco ranks 1st of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.